Effect of arsenic trioxide on cytokine expression by acute promyelocytic leukemia cells

被引:0
|
作者
Jiang, GS [1 ]
Bi, KH
Tang, TH
Zhang, YK
Ren, HQ
Jiang, FQ
Ren, QH
Zhen, G
Liu, CF
Peng, J
Guo, GY
Liu, XL
Tian, ZG
机构
[1] Shandong Univ, Shandong Acad Med Sci, Dept Hematooncol, Jinan 250062, Peoples R China
[2] Shandong Qianfoshan Hosp, Dept Hematol, Jinan 250014, Peoples R China
[3] Shandong Univ, Qilu Hosp, Hematooncol Ctr, Jinan 250012, Peoples R China
关键词
leukemia; promyelocytic; acute; cytokines; arsenic trioxide;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To detect the expression of cytokines by acute promyelocytic leukemia (APL) cells before and after exposure to arsenic trioxide. Methods Diagnoses were performed according to the FAB cytological classification criteria and cytogenetic criteria. Bone marrow or blood samples from APL patients were collected in heparinized tubes,then primary APL cells were separated by traditional Ficoll-Hypaque density centrifugation and purified after adherence to plastic surfaces. IL-1(beta), IL-6, IL-8, TNFalpha and G-CSF levels in the leukemia cell culture supernatants were detected by ELISA. At the same time, nitro blue tetrazolium (NBT) reduction test was used to detect the differentiation of APL cells. Results After 96 hours exposure to arsenic trioxide, 10-6 mol/L in vitro or 10 mg/d in vivo, APL cells showed a significant increase of IL-1(beta) (P<0.05) and G-CSF (P<0.05) production, and a significant decrease of IL-6 (P<0.05) and IL-8 (P<0.05). However, there was no obvious variation of TNFalpha when compared with APL cells without exposure to arsenic trioxide. On the other hand, the proliferation ratio of APL cells in vitro was statistically correlated to the IL-1(beta) secretion ratio or G-CSF secretion ratio. The cell number ratio in patients with detectable IL-1(beta) or G-CSF was higher than that without detectable IL-1(beta) or G-CSF. Conclusion IL-1(beta) and G-CSF secretion may play an important role in the proliferation of APL cells after exposure to arsenic trioxide.
引用
收藏
页码:1639 / 1643
页数:5
相关论文
共 50 条
  • [1] Effect of arsenic trioxide on cytokine expression by acute promyelocytic leukemia cells
    姜国胜
    毕可红
    唐天华
    张玉昆
    任海全
    姜枫勤
    任青华
    真刚
    刘传芳
    彭军
    郭桂月
    刘秀兰
    田志刚
    中华医学杂志(英文版), 2003, (11) : 41 - 45
  • [2] Effect of arsenic trioxide on cytokine expression by acute promyelocytic leukemia cells
    姜国胜
    毕可红
    唐天华
    张玉昆
    任海全
    姜枫勤
    任青华
    真刚
    刘传芳
    彭军
    郭桂月
    刘秀兰
    田志刚
    ChineseMedicalJournal, 2003, (11)
  • [3] Metabolism of Arsenic Trioxide in Acute Promyelocytic Leukemia Cells
    Khaleghian, Ali
    Ghaffari, Seyed H.
    Ahmadian, Shahin
    Alimoghaddam, Kamran
    Ghavamzadeh, Ardeshir
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2014, 115 (10) : 1729 - 1739
  • [4] Anticancer effect of arsenic trioxide in acute promyelocytic leukemia
    Kim, HS
    Chang, SJ
    Park, JH
    Cho, YJ
    Baek, WK
    Kwon, KY
    Kang, CM
    LEUKEMIA, 2001, 15 (03) : 509 - 509
  • [5] EFFECT OF ARSENIC TRIOXIDE ON NUCLEOSTEMIN GENE EXPRESSION IN ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS
    Ashrafi, F.
    Nadali, F.
    Alimoghadam, K.
    Rostami, S.
    Mosavi, S. A.
    Ghavamzadeh, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 358 - 358
  • [6] Arsenic trioxide in treatment of acute promyelocytic leukemia
    Ghavamzadeh, A
    Alimoghddam, K
    Aghdami, N
    Rastegarpanah, M
    Hosseini, R
    Tavassoli, P
    Jahani, M
    Khodabandeh, A
    Babordi, E
    Irvani, M
    Bahar, B
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 393 - 394
  • [7] Treatment of acute promyelocytic leukemia with arsenic trioxide
    Tamm, I
    Paternostro, G
    Zapata, JM
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (13): : 1043 - 1043
  • [8] Role of Arsenic Trioxide in Acute Promyelocytic Leukemia
    Iland, Harry J.
    Seymour, John F.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (02) : 170 - 184
  • [9] Arsenic trioxide: Acute promyelocytic leukemia and beyond
    Bachleitner-Hofmann, T
    Kees, M
    Gisslinger, H
    LEUKEMIA & LYMPHOMA, 2002, 43 (08) : 1535 - 1540
  • [10] Arsenic trioxide for the treatment of acute promyelocytic leukemia
    Lam, MSH
    Ignoffo, RJ
    CANCER PRACTICE, 2001, 9 (03) : 155 - 157